mRNA |
GDC-0941 |
FIMM |
pan-cancer |
AAC |
0.55 |
0.008 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.008 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.009 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |